Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in All of Us Research Program Participants, 2 January to 18 March 2020
KN Althoff, DJ Schlueter, H Anton-Culver… - Clinical Infectious …, 2022 - academic.oup.com
Background With limited severe acute respiratory syndrome coronavirus (SARS-CoV-2)
testing capacity in the United States at the start of the epidemic (January–March 2020) …
testing capacity in the United States at the start of the epidemic (January–March 2020) …
Prevalence of SARS-CoV-2 antibodies in New York City adults, June–October 2020: a population-based survey
JC Parrott, AN Maleki, VE Vassor… - The Journal of …, 2021 - academic.oup.com
Background Serosurveys help to ascertain burden of infection. Prior severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) serosurveys in New York City (NYC) used …
syndrome coronavirus 2 (SARS-CoV-2) serosurveys in New York City (NYC) used …
Seroprevalence of severe acute respiratory syndrome coronavirus 2 following the largest initial epidemic wave in the United States: findings from New York City, 13 …
P Pathela, A Crawley, D Weiss, B Maldin… - The Journal of …, 2021 - academic.oup.com
Abstract Background New York City (NYC) was the US epicenter of the spring 2020
coronavirus disease 2019 (COVID-19) pandemic. We present the seroprevalence of severe …
coronavirus disease 2019 (COVID-19) pandemic. We present the seroprevalence of severe …
Seroprevalence of SARS-CoV-2-specific IgG antibodies among adults living in Connecticut: Post-infection prevalence (PIP) study
S Mahajan, R Srinivasan, CA Redlich… - The American journal of …, 2021 - Elsevier
Background A seroprevalence study can estimate the percentage of people with severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies in the general …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies in the general …
[HTML][HTML] Severe acute respiratory syndrome coronavirus 2− specific antibody responses in coronavirus disease patients
A new coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has
recently emerged to cause a human pandemic. Although molecular diagnostic tests were …
recently emerged to cause a human pandemic. Although molecular diagnostic tests were …
Lack of antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a large cohort of previously infected persons
LR Petersen, S Sami, N Vuong… - Clinical Infectious …, 2021 - academic.oup.com
Background Reports suggest that some persons previously infected with severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) lack detectable immunoglobulin G (IgG) …
respiratory syndrome coronavirus 2 (SARS-CoV-2) lack detectable immunoglobulin G (IgG) …
Insights from patterns of SARS-CoV-2 immunoglobulin G serology test results from a national clinical laboratory, United States, March–July 2020
HW Kaufman, Z Chen, WA Meyer III… - Population health …, 2021 - liebertpub.com
Serologic tests for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) provide
information on past infection and immune response. To better understand the persistence of …
information on past infection and immune response. To better understand the persistence of …
SARS-CoV-2 serologic assays in control and unknown populations demonstrate the necessity of virus neutralization testing
Background To determine how serologic antibody testing outcome links with virus
neutralization of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), we …
neutralization of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), we …
Serologic testing of US blood donations to identify severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–reactive antibodies: December 2019–January …
SV Basavaraju, ME Patton, K Grimm… - Clinical Infectious …, 2021 - academic.oup.com
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that
causes coronavirus disease 2019 (COVID-19), was first identified in Wuhan, China, in …
causes coronavirus disease 2019 (COVID-19), was first identified in Wuhan, China, in …
[HTML][HTML] Association between severe acute respiratory syndrome coronavirus 2 antibody status and reinfection: A case-control study nested in a Colorado-based …
IA Binswanger, KJ Narwaney, JC Barrow… - Preventive Medicine …, 2024 - Elsevier
Objective The association between the presence of detectable antibodies to severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) and SARS-CoV-2 reinfection is not well …
respiratory syndrome coronavirus 2 (SARS-CoV-2) and SARS-CoV-2 reinfection is not well …